LTX-315 – a promising novel antitumor peptide and immunotherapeutic agent

Authors:

Dagmar Zweytick1,2
PDF Download PubMed Link
Affiliations:

1 Institute of Molecular Biosciences, Biophysics Division, University of Graz, Graz, Austria.

2 BioTechMed-Graz, Graz, Austria.

Keywords: 

antitumor peptide, immunotherapeutic agent, melanoma, sarcoma.

Corresponding Author(s):

Dagmar Zweytick, Phone: +43 316 4988; dagmar.zweytick@uni-graz.at

Conflict of interest statement:

No conflict of interest.

Please cite this article as:

Dagmar Zweytick (2019). LTX-315 – a promising novel antitumor peptide and immunotherapeutic agent Cell Stress 3(11): 328-329. doi: 10.15698/cst2019.11.202

© 2019 Zweytick. This is an open-access article released under the terms of the Creative Commons Attribution (CC BY) license, which allows the unrestricted use, distribution, and reproduction in any medium, provid-ed the original author and source are acknowledged.

Abstract: